FDA Drug Recalls

Recalls / Class II

Class IID-0217-2025

Product

Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.

Affected lot / code info
Lot #s: J0777493050824, Exp. 5/31/2025; J0787856062124, Exp. 7/31/2025.

Why it was recalled

CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.

Recalling firm

Firm
RemedyRepack Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
625 Kolter Dr Ste 4, Indiana, Pennsylvania 15701-3571

Distribution

Quantity
247 blister packs
Distribution pattern
FL

Timeline

Recall initiated
2025-01-24
FDA classified
2025-02-03
Posted by FDA
2025-02-12
Terminated
2025-07-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0217-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.